Fluvoxamine is currently used to treat mental health conditions such as depression and obsessive-compulsive disorders. It was chosen for study as a potential treatment for COVID-19 due to its anti-inflammatory properties.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3vRWhco
via IFTTT
0 comments:
Post a Comment